ReP USP - Resultado da busca

Parte de monografia/livro
O inimigo desconhecido (2024)
Segurado, Aluisio Augusto Cotrim ; Levin, Anna Sara Shafferman ; Kallas, Esper Georges
Source: Missão HC: Covid-19. Unidade: FM
Subjects: COVID-19, SAÚDE PÚBLICA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGURADO, Aluisio Augusto Cotrim e LEVIN, Anna Sara Shafferman e KALLAS, Esper Georges. O inimigo desconhecido. Missão HC: Covid-19. Tradução . São Paulo: Editora dos Editores, 2024. . . Acesso em: 09 nov. 2024.
APA
Segurado, A. A. C., Levin, A. S. S., & Kallas, E. G. (2024). O inimigo desconhecido. In Missão HC: Covid-19. São Paulo: Editora dos Editores.
NLM
Segurado AAC, Levin ASS, Kallas EG. O inimigo desconhecido. In: Missão HC: Covid-19. São Paulo: Editora dos Editores; 2024. [citado 2024 nov. 09 ]
Vancouver
Segurado AAC, Levin ASS, Kallas EG. O inimigo desconhecido. In: Missão HC: Covid-19. São Paulo: Editora dos Editores; 2024. [citado 2024 nov. 09 ]
Artigo de periodico
Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine (2024)
Izmirly, Abdullah M; Pelletier, Adam-Nicolas; Connors, Jennifer; Taramangalam, Bhavani; Alturki, Sawsan O; Gordon, Emma A; Alturki, Sana O; Mell, Joshua C; Swaminathan, Gokul; Kallas, Esper Georges
Source: Plos pathogens. Unidade: FM
Subjects: DENGUE, VACINAS, SISTEMA IMUNE, PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
IZMIRLY, Abdullah M et al. Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine. Plos pathogens, v. 18, n. 1, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56106. Acesso em: 09 nov. 2024.
APA
Izmirly, A. M., Pelletier, A. -N., Connors, J., Taramangalam, B., Alturki, S. O., Gordon, E. A., et al. (2024). Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine. Plos pathogens, 18( 1). doi:10.1371/journal.ppat.1009903
NLM
Izmirly AM, Pelletier A-N, Connors J, Taramangalam B, Alturki SO, Gordon EA, Alturki SO, Mell JC, Swaminathan G, Kallas EG. Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine [Internet]. Plos pathogens. 2024 ; 18( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56106
Vancouver
Izmirly AM, Pelletier A-N, Connors J, Taramangalam B, Alturki SO, Gordon EA, Alturki SO, Mell JC, Swaminathan G, Kallas EG. Pre-vaccination frequency of circulatory Tfh is associated with robust immune response to TV003 dengue vaccine [Internet]. Plos pathogens. 2024 ; 18( 1):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56106
Parte de monografia/livro
Sepse do pós-operatório (2024)
Almeida, Bianca Leal de; Souza, Dayenne Hianaê de Paula; Carvalho, Laína Bubach; Gouveia, Larissa Nunes de Almeida; Kallás, Esper Georges ; Ribeiro, Lucas Trindade Cantú
Source: O paciente cirúrgico de alto risco :condutas no perioperatório. Unidade: FM
Subjects: SEPSE, PERÍODO PÓS-OPERATÓRIO, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Bianca Leal de et al. Sepse do pós-operatório. O paciente cirúrgico de alto risco :condutas no perioperatório. Tradução . Rio de Janeiro: Atheneu, 2024. . . Acesso em: 09 nov. 2024.
APA
Almeida, B. L. de, Souza, D. H. de P., Carvalho, L. B., Gouveia, L. N. de A., Kallás, E. G., & Ribeiro, L. T. C. (2024). Sepse do pós-operatório. In O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu.
NLM
Almeida BL de, Souza DH de P, Carvalho LB, Gouveia LN de A, Kallás EG, Ribeiro LTC. Sepse do pós-operatório. In: O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu; 2024. [citado 2024 nov. 09 ]
Vancouver
Almeida BL de, Souza DH de P, Carvalho LB, Gouveia LN de A, Kallás EG, Ribeiro LTC. Sepse do pós-operatório. In: O paciente cirúrgico de alto risco :condutas no perioperatório. Rio de Janeiro: Atheneu; 2024. [citado 2024 nov. 09 ]
Monografia/livro
Missão HC: Covid-19 (2024)
Utiyama, Edivaldo Massazo ; Bonfa, Eloisa Silva Dutra de Oliveira ; Segurado, Aluisio Augusto Cotrim ; Duarte, Alberto José da Silva ; Xavier, Ana Claudia Latronico ; Levin, Anna Sara Shafferman ; Carvalho, Carlos Roberto Ribeiro De ; Tanaka, Clarice ; Andrade, Claudia Regina Furquim de ; Kallas, Esper Georges ; Sabino, Ester Cerdeira ; Miguel Filho, Eurípedes Constantino ; Jatene, Fábio Biscegli ; Galas, Filomena Regina Barbosa Gomes ; Busatto Filho, Geraldo ; Cerri, Giovanni Guido ; Battistella, Linamara Rizzo ; Andrade, Lucia da Conceição ; Hajjar, Ludhmila Abrahão ; Torres, Marcelo Luis Abramides ; Nunes, Maria do Patrocinio Tenorio ; Carmona, Maria Jose Carvalho ; Luccia, Nelson De ; Souza, Rogerio de ; Francisco, Rossana Pulcineli Vieira ; Lancman, Selma ; Costa, Sílvia Figueiredo ; Barros Filho, Tarcisio Eloy Pessoa de ; Ribeiro Junior, Ulysses ; Nahas, Willian Carlos
Unidade: FM
Subjects: COVID-19, SAÚDE PÚBLICA, SISTEMA ÚNICO DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UTIYAMA, Edivaldo Massazo et al. Missão HC: Covid-19. . São Paulo: Editora dos Editores. . Acesso em: 09 nov. 2024. , 2024
APA
Utiyama, E. M., Bonfa, E. S. D. de O., Segurado, A. A. C., Duarte, A. J. da S., Xavier, A. C. L., Levin, A. S. S., et al. (2024). Missão HC: Covid-19. São Paulo: Editora dos Editores.
NLM
Utiyama EM, Bonfa ESD de O, Segurado AAC, Duarte AJ da S, Xavier ACL, Levin ASS, Carvalho CRRD, Tanaka C, Andrade CRF de, Kallas EG, Sabino EC, Miguel Filho EC, Jatene FB, Galas FRBG, Busatto Filho G, Cerri GG, Battistella LR, Andrade L da C, Hajjar LA, Torres MLA, Nunes M do PT, Carmona MJC, Luccia ND, Souza R de, Francisco RPV, Lancman S, Costa SF, Barros Filho TEP de, Ribeiro Junior U, Nahas WC. Missão HC: Covid-19. 2024 ;[citado 2024 nov. 09 ]
Vancouver
Utiyama EM, Bonfa ESD de O, Segurado AAC, Duarte AJ da S, Xavier ACL, Levin ASS, Carvalho CRRD, Tanaka C, Andrade CRF de, Kallas EG, Sabino EC, Miguel Filho EC, Jatene FB, Galas FRBG, Busatto Filho G, Cerri GG, Battistella LR, Andrade L da C, Hajjar LA, Torres MLA, Nunes M do PT, Carmona MJC, Luccia ND, Souza R de, Francisco RPV, Lancman S, Costa SF, Barros Filho TEP de, Ribeiro Junior U, Nahas WC. Missão HC: Covid-19. 2024 ;[citado 2024 nov. 09 ]
Artigo de periodico
Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection (2024)
Ricciardi, Michael J ; Rust, Lauren N ; Pedreno-lopez, Nuria ; Yusova, Sofiya ; Biswas, Sreya ; Webb, Gabriela M; Gonzalez-Nieto, Lucas ; Voigt, Thomas B ; Louw, Johan J ; Laurino, Fernanda D ; Kallas, Esper Georges
Source: Science translational medicine. Unidade: FM
Subjects: VETORES, FEBRE AMARELA, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RICCIARDI, Michael J et al. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, v. 15, n. 689, 2024Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53922. Acesso em: 09 nov. 2024.
APA
Ricciardi, M. J., Rust, L. N., Pedreno-lopez, N., Yusova, S., Biswas, S., Webb, G. M., et al. (2024). Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection. Science translational medicine, 15( 689). doi:10.1126/scitranslmed.ade5795
NLM
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922
Vancouver
Ricciardi MJ, Rust LN, Pedreno-lopez N, Yusova S, Biswas S, Webb GM, Gonzalez-Nieto L, Voigt TB, Louw JJ, Laurino FD, Kallas EG. Therapeutic neutralizing monoclonal antibody administration protects against lethal yellow fever virus infection [Internet]. Science translational medicine. 2024 ; 15( 689):[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53922
Artigo de periodico
Viral Kinetics in Sylvatic Yellow Fever Cases (2023)
Silva, Vivian Helena Iida Avelino da ; Thomazella, Mateus Vailant ; Marmorato, Mariana Prado ; Correia, Carolina Argondizo ; Dias, Juliana Zanatta de Carvalho; Maestri, Alvino; Cerqueira, Natalia Barros; Moreira, Carlos Henrique Valente ; Buccheri, Renata ; Félix, Alvina Clara ; Zanella, Luiz Gonzaga Francisco de Assis Barros D'Elia ; Costa, Priscilla Ramos; Kallas, Esper Georges
Source: Journal of infectious diseases. Unidade: FM
Subjects: CARGA VIRAL, FEBRE AMARELA, DOENÇAS INFECCIOSAS, MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vivian Helena Iida Avelino da et al. Viral Kinetics in Sylvatic Yellow Fever Cases. Journal of infectious diseases, v. 227, n. 9, p. 1097-1103, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53927. Acesso em: 09 nov. 2024.
APA
Silva, V. H. I. A. da, Thomazella, M. V., Marmorato, M. P., Correia, C. A., Dias, J. Z. de C., Maestri, A., et al. (2023). Viral Kinetics in Sylvatic Yellow Fever Cases. Journal of infectious diseases, 227( 9), 1097-1103. doi:10.1093/infdis/jiac435
NLM
Silva VHIA da, Thomazella MV, Marmorato MP, Correia CA, Dias JZ de C, Maestri A, Cerqueira NB, Moreira CHV, Buccheri R, Félix AC, Zanella LGF de ABD'E, Costa PR, Kallas EG. Viral Kinetics in Sylvatic Yellow Fever Cases [Internet]. Journal of infectious diseases. 2023 ; 227( 9): 1097-1103.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53927
Vancouver
Silva VHIA da, Thomazella MV, Marmorato MP, Correia CA, Dias JZ de C, Maestri A, Cerqueira NB, Moreira CHV, Buccheri R, Félix AC, Zanella LGF de ABD'E, Costa PR, Kallas EG. Viral Kinetics in Sylvatic Yellow Fever Cases [Internet]. Journal of infectious diseases. 2023 ; 227( 9): 1097-1103.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53927
Artigo de periodico
Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial (2023)
Landovitz, Raphael J; Hanscom, Brett S; Clement, Meredith E; Tran, Ha V; Kallas, Esper Georges ; Magnus, Manya; Sued, Omar; Sanchez, Jorge; Scott, Hyman; Eron, Joe J
Source: Lancet HIV. Unidade: FM
Subjects: PESSOAS TRANSGÊNERO, HIV, PREVENÇÃO DE DOENÇAS, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANDOVITZ, Raphael J et al. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV, v. 10, n. 12, p. E767-E778, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57947. Acesso em: 09 nov. 2024.
APA
Landovitz, R. J., Hanscom, B. S., Clement, M. E., Tran, H. V., Kallas, E. G., Magnus, M., et al. (2023). Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial. Lancet HIV, 10( 12), E767-E778. doi:10.1016/S2352-3018(23)00261-8
NLM
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial [Internet]. Lancet HIV. 2023 ; 10( 12): E767-E778.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57947
Vancouver
Landovitz RJ, Hanscom BS, Clement ME, Tran HV, Kallas EG, Magnus M, Sued O, Sanchez J, Scott H, Eron JJ. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial [Internet]. Lancet HIV. 2023 ; 10( 12): E767-E778.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57947
Artigo de periodico
Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data (2023)
Silva, Vivian Helena Iida Avelino da ; Silva, Thiago Junqueira Avelino da ; Aliberti, Márlon Juliano Romero ; Ferreira, Juliana Carvalho ; Cobello Junior, Vilson ; Silva, Katia Regina da ; Pompeu, José Eduardo ; Antonangelo, Leila ; Magri, Marcello Mihailenko Chaves ; Barros Filho, Tarcisio Eloy Pessoa de ; Souza, Heraldo Possolo de ; Kallas, Esper Georges
Source: Clinics. Unidades: FM, EE
Subjects: COVID-19, UNIDADES DE TERAPIA INTENSIVA, ESTUDOS RETROSPECTIVOS, PACIENTES INTERNADOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Vivian Helena Iida Avelino da et al. Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data. Clinics, v. 78, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53890. Acesso em: 09 nov. 2024.
APA
Silva, V. H. I. A. da, Silva, T. J. A. da, Aliberti, M. J. R., Ferreira, J. C., Cobello Junior, V., Silva, K. R. da, et al. (2023). Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data. Clinics, 78. doi:10.1016/j.clinsp.2023.100183
NLM
Silva VHIA da, Silva TJA da, Aliberti MJR, Ferreira JC, Cobello Junior V, Silva KR da, Pompeu JE, Antonangelo L, Magri MMC, Barros Filho TEP de, Souza HP de, Kallas EG. Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data [Internet]. Clinics. 2023 ; 78[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53890
Vancouver
Silva VHIA da, Silva TJA da, Aliberti MJR, Ferreira JC, Cobello Junior V, Silva KR da, Pompeu JE, Antonangelo L, Magri MMC, Barros Filho TEP de, Souza HP de, Kallas EG. Prediction of intensive care admission and hospital mortality in COVID-19 patients using demographics and baseline laboratory data [Internet]. Clinics. 2023 ; 78[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53890
Artigo de periodico
Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) (2023)
Bonifácio, Lívia Pimenta ; Ramacciotti, Eduardo ; Agati, Leandro Barile ; Vilar, Fernando Crivelenti; Silva, Anna Christina Tojal da; Louzada Junior, Paulo; Fonseca, Benedito Antonio Lopes da; Souza, Hayala Cristina Cavenague de; Oliveira, Caroline Candida Carvalho de; Aguiar, Valeria Cristina Resende; Kallas, Esper Georges ; Rodrigues, Fernando Bellíssimo
Source: Revista da sociedade brasileira de medicina tropical. Unidades: FMRP, FM
Subjects: COVID-19, PACIENTES INTERNADOS, PANDEMIAS, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BONIFÁCIO, Lívia Pimenta et al. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, v. 56, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/54695. Acesso em: 09 nov. 2024.
APA
Bonifácio, L. P., Ramacciotti, E., Agati, L. B., Vilar, F. C., Silva, A. C. T. da, Louzada Junior, P., et al. (2023). Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors). Revista da sociedade brasileira de medicina tropical, 56. doi:10.1590/0037-8682-0565-2022
NLM
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Vancouver
Bonifácio LP, Ramacciotti E, Agati LB, Vilar FC, Silva ACT da, Louzada Junior P, Fonseca BAL da, Souza HCC de, Oliveira CCC de, Aguiar VCR, Kallas EG, Rodrigues FB. Efficacy and safety of Ixekizumab vs. low-dose IL-2 vs. Colchicine vs. standard of care in the treatment of patients hospitalized with moderate-to-critical COVID-19: A pilot randomized clinical trial (STRUCK: Survival Trial Using Cytokine Inhibitors) [Internet]. Revista da sociedade brasileira de medicina tropical. 2023 ; 56[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/54695
Artigo de periodico
Encephalopathy caused by human parvovirus B19 genotype 1 associated with Haemophilus influenzae Meningitis in a Newborn (2023)
Ferreira, Noely Evangelista; Costa, Antonio C. da; Kallas, Esper Georges ; Silveira, Cassia G. T; Oliveira, Ana Carolina S. de; Honorato, Layla; Lima, Silvia Helena de; Costa, Sílvia Figueiredo ; Mendoza, Tânia Regina Tozetto ; Correa, Maria Cássia Jacintho Mendes
Source: CURRENT ISSUES IN MOLECULAR BIOLOGY. Unidade: FM
Subjects: RECÉM-NASCIDO, MENINGOENCEFALITE, DOENÇAS CEREBRAIS, GENES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERREIRA, Noely Evangelista et al. Encephalopathy caused by human parvovirus B19 genotype 1 associated with Haemophilus influenzae Meningitis in a Newborn. CURRENT ISSUES IN MOLECULAR BIOLOGY, v. 45, n. 9, p. 6958-6966, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/57950. Acesso em: 09 nov. 2024.
APA
Ferreira, N. E., Costa, A. C. da, Kallas, E. G., Silveira, C. G. T., Oliveira, A. C. S. de, Honorato, L., et al. (2023). Encephalopathy caused by human parvovirus B19 genotype 1 associated with Haemophilus influenzae Meningitis in a Newborn. CURRENT ISSUES IN MOLECULAR BIOLOGY, 45( 9), 6958-6966. doi:10.3390/cimb45090439
NLM
Ferreira NE, Costa AC da, Kallas EG, Silveira CGT, Oliveira ACS de, Honorato L, Lima SH de, Costa SF, Mendoza TRT, Correa MCJM. Encephalopathy caused by human parvovirus B19 genotype 1 associated with Haemophilus influenzae Meningitis in a Newborn [Internet]. CURRENT ISSUES IN MOLECULAR BIOLOGY. 2023 ; 45( 9): 6958-6966.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57950
Vancouver
Ferreira NE, Costa AC da, Kallas EG, Silveira CGT, Oliveira ACS de, Honorato L, Lima SH de, Costa SF, Mendoza TRT, Correa MCJM. Encephalopathy caused by human parvovirus B19 genotype 1 associated with Haemophilus influenzae Meningitis in a Newborn [Internet]. CURRENT ISSUES IN MOLECULAR BIOLOGY. 2023 ; 45( 9): 6958-6966.[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/57950
Artigo de periodico
Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls (2023)
Pereira-Manfro, Wania Ferraz; Silva, Giselle Pereira da; Costa, Priscilla Ramos; Costa, Dayane Alves; Ferreira, Bianca da Silva; Barreto, Daniela Mena; Frota, Ana Cristina Cisne; Hofer, Cristina Barroso; Kallas, Esper Georges ; Milagres, Lucimar Goncalves
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: HIV, INFECÇÕES POR HIV, BIOMARCADORES, CRIANÇAS, ADOLESCENTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA-MANFRO, Wania Ferraz et al. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls. Revista do instituto de medicina tropical de sao paulo, v. 65, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/52957. Acesso em: 09 nov. 2024.
APA
Pereira-Manfro, W. F., Silva, G. P. da, Costa, P. R., Costa, D. A., Ferreira, B. da S., Barreto, D. M., et al. (2023). Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls. Revista do instituto de medicina tropical de sao paulo, 65. doi:10.1590/S1678-9946202365014
NLM
Pereira-Manfro WF, Silva GP da, Costa PR, Costa DA, Ferreira B da S, Barreto DM, Frota ACC, Hofer CB, Kallas EG, Milagres LG. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52957
Vancouver
Pereira-Manfro WF, Silva GP da, Costa PR, Costa DA, Ferreira B da S, Barreto DM, Frota ACC, Hofer CB, Kallas EG, Milagres LG. Expression of TIGIT, PD-1 and HLA-DR/CD38 markers on CD8-T cells of children and adolescents infected with HIV and uninfected controls [Internet]. Revista do instituto de medicina tropical de sao paulo. 2023 ; 65[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/52957
Artigo de periodico
Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors (2023)
Gil, Saulo ; Gualano, Bruno ; Araújo, Adriana Ladeira de; Oliveira Junior, Gersiel Nascimento de ; Damiano, Rodolfo Furlan ; Pinna, Fabio de Rezende ; Imamura, Marta ; Rocha, Vanderson ; Kallas, Esper Georges ; Batistella, Linamara Rizzo; Forlenza, Orestes Vicente ; Carvalho, Carlos Roberto Ribeiro De ; Busatto Filho, Geraldo ; Roschel, Hamilton ; HCFMUSP COVID-19 Study Group
Source: Scientific Reports. Unidades: FM, EEFE
Subjects: COVID-19, SEDENTARISMO, QUALIDADE DE VIDA, PROGNÓSTICO, ATIVIDADE FÍSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GIL, Saulo et al. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Scientific Reports, v. 13, 2023Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-26888-3. Acesso em: 09 nov. 2024.
APA
Gil, S., Gualano, B., Araújo, A. L. de, Oliveira Junior, G. N. de, Damiano, R. F., Pinna, F. de R., et al. (2023). Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors. Scientific Reports, 13. doi:10.1038/s41598-022-26888-3
NLM
Gil S, Gualano B, Araújo AL de, Oliveira Junior GN de, Damiano RF, Pinna F de R, Imamura M, Rocha V, Kallas EG, Batistella LR, Forlenza OV, Carvalho CRRD, Busatto Filho G, Roschel H, HCFMUSP COVID-19 Study Group. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors [Internet]. Scientific Reports. 2023 ; 13[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-022-26888-3
Vancouver
Gil S, Gualano B, Araújo AL de, Oliveira Junior GN de, Damiano RF, Pinna F de R, Imamura M, Rocha V, Kallas EG, Batistella LR, Forlenza OV, Carvalho CRRD, Busatto Filho G, Roschel H, HCFMUSP COVID-19 Study Group. Post-acute sequelae of SARS-CoV-2 associates with physical inactivity in a cohort of COVID-19 survivors [Internet]. Scientific Reports. 2023 ; 13[citado 2024 nov. 09 ] Available from: https://doi.org/10.1038/s41598-022-26888-3
Artigo de periodico
Humoral and cellular immune responses to CoronaVac up to one year after vaccination (2022)
Costa, Priscilla Ramos; Correia, Carolina Argondizo ; Marmorato, Mariana Prado ; Dias, Juliana Zanatta de Carvalho; Thomazella, Mateus Vailant ; Silva, Amanda Cabral da; Oliveira, Ana Carolina Soares de; Gusmao, Arianne Fagotti; Ferrari, Lilian; Freitas, Angela Carvalho ; Kallas, Esper Georges
Source: Frontiers in immunology. Unidade: FM
Subjects: COVID-19, VACINAS VIRAIS, SISTEMA IMUNE, CITOCINAS, ANTÍGENOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Priscilla Ramos et al. Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, v. 13, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50534. Acesso em: 09 nov. 2024.
APA
Costa, P. R., Correia, C. A., Marmorato, M. P., Dias, J. Z. de C., Thomazella, M. V., Silva, A. C. da, et al. (2022). Humoral and cellular immune responses to CoronaVac up to one year after vaccination. Frontiers in immunology, 13. doi:10.3389/fimmu.2022.1032411
NLM
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Vancouver
Costa PR, Correia CA, Marmorato MP, Dias JZ de C, Thomazella MV, Silva AC da, Oliveira ACS de, Gusmao AF, Ferrari L, Freitas AC, Kallas EG. Humoral and cellular immune responses to CoronaVac up to one year after vaccination [Internet]. Frontiers in immunology. 2022 ; 13[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50534
Artigo de periodico
Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil (2022)
Petruccelli, Karla Cristina Silva; Baia-da-Silva, Djane Clarys; Val, Fernando; Valoes, Monica Santos; Cubas-Vega, Nadia; Silva-Neto, Alexandre Vilhena; Sampaio, Vanderson; Alencar, Aline; Pecoits-Filho, Roberto; Moreira, Rodrigo Carvalho; Kallas, Esper Georges
Source: Aids research and therapy. Unidade: FM
Subjects: SÍNDROME DE IMUNODEFICIÊNCIA ADQUIRIDA, ESTUDOS MULTICÊNTRICOS, TRANSPLANTE DE RIM, FÁRMACOS IMUNOSSUPRESSORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PETRUCCELLI, Karla Cristina Silva et al. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. Aids research and therapy, v. 19, n. 1, 2022Tradução . . Disponível em: https://doi.org/10.1186/s12981-022-00437-4. Acesso em: 09 nov. 2024.
APA
Petruccelli, K. C. S., Baia-da-Silva, D. C., Val, F., Valoes, M. S., Cubas-Vega, N., Silva-Neto, A. V., et al. (2022). Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil. Aids research and therapy, 19( 1). doi:10.1186/s12981-022-00437-4
NLM
Petruccelli KCS, Baia-da-Silva DC, Val F, Valoes MS, Cubas-Vega N, Silva-Neto AV, Sampaio V, Alencar A, Pecoits-Filho R, Moreira RC, Kallas EG. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 nov. 09 ] Available from: https://doi.org/10.1186/s12981-022-00437-4
Vancouver
Petruccelli KCS, Baia-da-Silva DC, Val F, Valoes MS, Cubas-Vega N, Silva-Neto AV, Sampaio V, Alencar A, Pecoits-Filho R, Moreira RC, Kallas EG. Kidney function and daily emtricitabine/tenofovir disoproxil fumarate pre-exposure prophylaxis against HIV: results from the real-life multicentric demonstrative project PrEP Brazil [Internet]. Aids research and therapy. 2022 ; 19( 1):[citado 2024 nov. 09 ] Available from: https://doi.org/10.1186/s12981-022-00437-4
Artigo de periodico
Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis (2022)
Medeiros-Ribeiro, Ana Cristina; Bonfiglioli, Karina Rossi; Domiciano, Diogo Souza; Shimabuco, Andrea Yukie; Silva, Henrique Carrico da; Saad, Carla G. S.; Yuki, Emily Figueiredo Neves; Pasoto, Sandra Gofinet; Araujo, Carlo Scognamiglio Renner; Nakai, Tatiane Lie; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Annals of the rheumatic diseases. Unidade: FM
Subjects: FÁRMACOS DO SANGUE E SISTEMA HEMATOPOÉTICO, ESTUDOS PROSPECTIVOS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEDEIROS-RIBEIRO, Ana Cristina et al. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, v. 81, n. 5, p. 710-719, 2022Tradução . . Disponível em: https://doi.org/10.1136/annrheumdis-2021-221735. Acesso em: 09 nov. 2024.
APA
Medeiros-Ribeiro, A. C., Bonfiglioli, K. R., Domiciano, D. S., Shimabuco, A. Y., Silva, H. C. da, Saad, C. G. S., et al. (2022). Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis. Annals of the rheumatic diseases, 81( 5), 710-719. doi:10.1136/annrheumdis-2021-221735
NLM
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Vancouver
Medeiros-Ribeiro AC, Bonfiglioli KR, Domiciano DS, Shimabuco AY, Silva HC da, Saad CGS, Yuki EFN, Pasoto SG, Araujo CSR, Nakai TL, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Distinct impact of DMARD combination and monotherapy in immunogenicity of an inactivated SARS-CoV-2 vaccine in rheumatoid arthritis [Internet]. Annals of the rheumatic diseases. 2022 ; 81( 5): 710-719.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1136/annrheumdis-2021-221735
Artigo de periodico
Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers (2022)
Luna-Muschi, Alessandra; Borges, Igor C; Faria, Elizabeth de; Barboza, Antonio S; Maia, Fernando L; Leme, Mariana D; Guedes, Ana Rubia; Correa, Maria Cássia Jacintho Mendes ; Kallas, Esper Georges ; Segurado, Aluisio Augusto Cotrim ; Sabino, Ester Cerdeira ; Levin, Anna Sara Shafferman ; Costa, Sílvia Figueiredo
Source: Journal of infection. Unidades: FM, RUSP
Subjects: ARTIGOS DE PERIÓDICOS, VACINAÇÃO, COVID-19, ESTUDOS DE COORTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUNA-MUSCHI, Alessandra et al. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, v. 84, n. 2, p. 262-265, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.jinf.2021.09.005. Acesso em: 09 nov. 2024.
APA
Luna-Muschi, A., Borges, I. C., Faria, E. de, Barboza, A. S., Maia, F. L., Leme, M. D., et al. (2022). Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers. Journal of infection, 84( 2), 262-265. doi:10.1016/j.jinf.2021.09.005
NLM
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Vancouver
Luna-Muschi A, Borges IC, Faria E de, Barboza AS, Maia FL, Leme MD, Guedes AR, Correa MCJM, Kallas EG, Segurado AAC, Sabino EC, Levin ASS, Costa SF. Clinical features of COVID-19 by SARS-CoV-2 Gamma variant: a prospective cohort study of vaccinated and unvaccinated healthcare workers [Internet]. Journal of infection. 2022 ; 84( 2): 262-265.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.jinf.2021.09.005
Artigo de periodico
Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction (2022)
Oliveira, Beatriz Araujo; Oliveira, Lea Campos de; Oliveira, Franciane Mendes de; Pereira, Geovana Maria ; Souza, Regina Maia de; Manuli, Erika Regina ; Marchini, Fabricio Klerynton; Espinoza, Evelyn Patricia Sanchez; Park, Marcelo ; Taniguchi, Leandro Utino ; Kallas, Esper Georges ; Levin, Anna Sara Shafferman ; Sabino, Ester Cerdeira ; Costa, Sílvia Figueiredo
Source: Revista do instituto de medicina tropical de sao paulo. Unidade: FM
Subjects: COVID-19, ENSAIOS QUÍMICOS, IMUNOHISTOQUÍMICA, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Beatriz Araujo et al. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction. Revista do instituto de medicina tropical de sao paulo, v. 64, 2022Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/50558. Acesso em: 09 nov. 2024.
APA
Oliveira, B. A., Oliveira, L. C. de, Oliveira, F. M. de, Pereira, G. M., Souza, R. M. de, Manuli, E. R., et al. (2022). Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction. Revista do instituto de medicina tropical de sao paulo, 64. doi:10.1590/S1678-9946202264063
NLM
Oliveira BA, Oliveira LC de, Oliveira FM de, Pereira GM, Souza RM de, Manuli ER, Marchini FK, Espinoza EPS, Park M, Taniguchi LU, Kallas EG, Levin ASS, Sabino EC, Costa SF. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50558
Vancouver
Oliveira BA, Oliveira LC de, Oliveira FM de, Pereira GM, Souza RM de, Manuli ER, Marchini FK, Espinoza EPS, Park M, Taniguchi LU, Kallas EG, Levin ASS, Sabino EC, Costa SF. Evaluation of eleven immunochromatographic assays for SARS-CoV-2 detection: investigating the dengue cross-reaction [Internet]. Revista do instituto de medicina tropical de sao paulo. 2022 ; 64[citado 2024 nov. 09 ] Available from: https://observatorio.fm.usp.br/handle/OPI/50558
Artigo de periodico
Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis (2022)
Correa, Frederico J. S; Andres, Marina Paula; Rocha, Taina Pezzin; Carvalho, Ana Eduarda Z; Aloia, Thiago P. A; Corpa, Marcus V. N; Kallas, Esper Georges ; Mangueira, Cristovao L. P; Baracat, Edmund Chada ; I, Karina Carvalho; Abrão, Maurício Simões
Source: Clinics. Unidade: FM
Subjects: ENDOMETRIOSE, APOPTOSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORREA, Frederico J. S et al. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics, v. 77, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.clinsp.2022.100032. Acesso em: 09 nov. 2024.
APA
Correa, F. J. S., Andres, M. P., Rocha, T. P., Carvalho, A. E. Z., Aloia, T. P. A., Corpa, M. V. N., et al. (2022). Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis. Clinics, 77. doi:10.1016/j.clinsp.2022.100032
NLM
Correa FJS, Andres MP, Rocha TP, Carvalho AEZ, Aloia TPA, Corpa MVN, Kallas EG, Mangueira CLP, Baracat EC, I KC, Abrão MS. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100032
Vancouver
Correa FJS, Andres MP, Rocha TP, Carvalho AEZ, Aloia TPA, Corpa MVN, Kallas EG, Mangueira CLP, Baracat EC, I KC, Abrão MS. Invariant Natural Killer T-cells and their subtypes may play a role in the pathogenesis of endometriosis [Internet]. Clinics. 2022 ; 77[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.clinsp.2022.100032
Artigo de periodico
Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus (2022)
Yuki, Emily F. N; Borba Neto, Eduardo Ferreira ; Pasoto, Sandra G; Seguro, Luciana P; Lopes, Michelle; Saad, Carla G. S; Silva, Clovis Artur Almeida da ; Kupa, Leonard de Vinci Kanda ; Kallas, Esper Georges ; Bonfa, Eloisa Silva Dutra de Oliveira
Source: Arthritis care & research. Unidade: FM
Subjects: ANTICORPOS, VACINAS VIRAIS, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YUKI, Emily F. N et al. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, v. 74, n. 4, p. 562-571, 2022Tradução . . Disponível em: https://doi.org/10.1002/acr.24824. Acesso em: 09 nov. 2024.
APA
Yuki, E. F. N., Borba Neto, E. F., Pasoto, S. G., Seguro, L. P., Lopes, M., Saad, C. G. S., et al. (2022). Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus. Arthritis care & research, 74( 4), 562-571. doi:10.1002/acr.24824
NLM
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/acr.24824
Vancouver
Yuki EFN, Borba Neto EF, Pasoto SG, Seguro LP, Lopes M, Saad CGS, Silva CAA da, Kupa L de VK, Kallas EG, Bonfa ESD de O. Impact of distinct therapies on antibody response to SARS-CoV-2 vaccine in systemic lupus erythematosus [Internet]. Arthritis care & research. 2022 ; 74( 4): 562-571.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/acr.24824
Artigo de periodico
Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) (2022)
Song, Alice Tung Wan ; Rocha, Vanderson Geraldo ; Mendrone Júnior, Alfredo ; Rodrigues, Rodrigo do Tocantins Calado de Saloma ; Santis, Gil Cunha De ; Benites, Bruno D. ; Lima, Carolina Costa ; Vargas, Taiani ; Marques, Leonardo da Silva ; Fernandes, Juliana C. ; Breda, Felipe C.; Wendel, Silvano ; Fachini, Roberta; Rizzo, Luiz V. ; Kutner, José Mauro ; Silva, Vivian Helena Iida Avelino da ; Machado, Rafael Rahal Guaragna ; Durigon, Edison Luiz ; Chevret, Sylvie ; Kallas, Esper Georges
Source: Lancet Regional Health. Americas. Unidades: FM, FMRP, ICB
Subjects: MICROBIOLOGIA, COVID-19, ENSAIO CLÍNICO CONTROLADO RANDOMIZADO, PLASMA, SANGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SONG, Alice Tung Wan et al. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, v. 10, p. 1-10, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.lana.2022.100216. Acesso em: 09 nov. 2024.
APA
Song, A. T. W., Rocha, V. G., Mendrone Júnior, A., Rodrigues, R. do T. C. de S., Santis, G. C. D., Benites, B. D., et al. (2022). Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI). Lancet Regional Health. Americas, 10, 1-10. doi:10.1016/j.lana.2022.100216
NLM
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.lana.2022.100216
Vancouver
Song ATW, Rocha VG, Mendrone Júnior A, Rodrigues R do TC de S, Santis GCD, Benites BD, Lima CC, Vargas T, Marques L da S, Fernandes JC, Breda FC, Wendel S, Fachini R, Rizzo LV, Kutner JM, Silva VHIA da, Machado RRG, Durigon EL, Chevret S, Kallas EG. Treatment of severe COVID-19 patients with either low- or high-volume of convalescent plasma versus standard of care: A multicenter Bayesian randomized open-label clinical trial (COOP-COVID-19-MCTI) [Internet]. Lancet Regional Health. Americas. 2022 ; 10 1-10.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.lana.2022.100216

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Countries/Territories

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration